Reuters logo
BRIEF-TCM Biotech International signs marketing and distribution contract on drug ACLASTA
April 6, 2017 / 7:10 AM / 6 months ago

BRIEF-TCM Biotech International signs marketing and distribution contract on drug ACLASTA

April 6 (Reuters) - TCM Biotech International Corp :

* Says the company enters into contract with a chemical pharmacy firm on marketing and distribution of ACLASTA, a kind of drug for treatment of osteoporosis

* Contract will be valid from March 17, 2017 to March 31, 2019

Source text in Chinese: goo.gl/zwkcTO

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below